According to research reviewed by Gram, a gut-derived inflammatory toxin called lipopolysaccharide strengthened blood pressure responses to muscle activity in diabetic rats, with a pressure-sensing protein called Piezo1 appearing to be involved. The 2026 study found these responses were significantly greater in rats with type 2 diabetes than in healthy rats. Results come from animal and cell experiments.
Gram Research analysis of a 2026 study in the journal Hypertension looked at why people with type 2 diabetes often have sharp blood pressure jumps during exercise. Researchers fed rats a high-fat diet and gave them a small dose of a drug that affects blood sugar, creating rats with type 2 diabetes. Nerves in the muscles of these rats sent stronger signals when the muscles were squeezed or stretched, which raised blood pressure more than in healthy rats. The team then found that lipopolysaccharide, an inflammatory toxin from gut bacteria, made these signals even stronger. It appeared to do this by increasing a pressure-sensing protein called Piezo1 on nerve cell surfaces. When a cell enzyme called PKA was blocked, this effect was reduced. These findings suggest a possible link between gut health, inflammation, and exercise-related blood pressure changes. Because the work was done in rats, it does not yet show what happens in people.
Key Statistics
A 2026 study published in the journal Hypertension found that rats with type 2 diabetes had significantly greater blood pressure and nerve responses to muscle activation than healthy rats.
A 2026 rat study published in Hypertension found that lipopolysaccharide, an inflammatory toxin from gut bacteria, significantly increased the amount of Piezo1 protein in cell membranes, and this increase was reduced when a PKA inhibitor was applied.
The Quick Take
- What they studied: The researchers wanted to know why people with type 2 diabetes often have bigger blood pressure increases during exercise, and whether signals from working muscles and gut inflammation play a role.
- Who participated: The study used laboratory rats of a common research type. Some were made to have type 2 diabetes using a high-fat diet and a small dose of a blood sugar drug, and others served as healthy comparisons. The exact number of rats was not stated in the information provided.
- Key finding: Rats with type 2 diabetes had significantly stronger blood pressure and nerve responses when their muscles were activated than healthy rats. Adding a gut-derived inflammatory toxin made these responses stronger still, and this appeared to involve a pressure-sensing protein called Piezo1.
- What it means for you: This research is at an early stage and was done in animals, so it cannot yet tell people how to change their blood pressure during exercise. It does point to gut health and inflammation as possible areas for future study. Anyone with diabetes or blood pressure concerns should talk with their doctor before changing their exercise or diet.
The Research Details
The researchers used rats that were fed a high-fat diet and given a low dose of streptozotocin, a chemical that damages insulin-producing cells. This combination was used to create rats that resemble people with type 2 diabetes. The team then studied these rats in two main ways. In some experiments, they kept the rats under anesthesia with part of the brain removed, which allowed them to measure blood pressure and nerve activity while the muscle reflex was triggered. In other experiments, they removed nerve fibers from muscles and recorded their electrical signals in a dish, one fiber at a time.
To test the role of Piezo1, the team used a chemical called Yoda1 that activates this protein. They also gave some rats lipopolysaccharide, a toxin from gut bacteria that causes inflammation. In a separate set of lab tests using human kidney cells grown in a dish, they measured how much Piezo1 reached the cell surface and whether a PKA inhibitor, a drug that blocks a cell enzyme, changed that amount.
This step-by-step approach let the researchers connect what happened in the whole animal to what happened in individual nerve fibers and single cells. Each experiment checked a different link in the proposed chain of events.
Using whole animals, isolated nerves, and cell cultures together helps show that a finding is not limited to one type of test. If blood pressure changes, nerve firing, and protein levels all move in the same direction, it is more convincing that a real biological pathway is involved. Testing the toxin and the blocking drug also helps show cause and effect rather than simple coincidence.
Animal models are also useful because researchers can control diet, toxin exposure, and drug doses in ways that are not possible in people. This makes it easier to isolate one mechanism at a time. However, rats are not identical to humans, so the results are best viewed as clues for further research.
The study uses several complementary methods, which strengthens confidence in its internal logic. The sample size was not specified in the information provided, so it is difficult to judge how many animals were studied or how much variation there was between them. Results from small animal studies often need to be confirmed in larger groups and in human studies before they can guide care.
The work was published in Hypertension, a journal focused on blood pressure research and generally subject to peer review. Still, the study is preliminary, and readers should treat its findings as promising leads rather than settled facts.
What the Results Show
The main finding was that rats with type 2 diabetes showed stronger blood pressure and nerve activity responses when their muscles were activated. When the researchers triggered the muscle reflex, these rats had larger rises in blood pressure and greater sympathetic nerve activity, which is the body’s automatic system that speeds up heart rate and narrows blood vessels. This pattern matches the exaggerated blood pressure responses that are sometimes seen in people with type 2 diabetes during exercise.
When the researchers looked at individual nerve fibers from the muscles, the fibers from diabetic rats fired more often in response to physical pressure and to the Piezo1-activating chemical Yoda1. This suggests that the nerve endings in diabetic muscle were more sensitive to mechanical signals, meaning they responded to smaller amounts of squeezing or stretching.
The researchers then gave rats lipopolysaccharide, a toxin from gut bacteria, and found that it made the Piezo1-driven blood pressure rises and nerve firing even stronger. In cell experiments, the toxin also increased the amount of Piezo1 protein reaching the cell membrane, which is the outer boundary of the cell where signals are received. When the PKA inhibitor was added, this increase was reduced. Together, these results suggest a chain of events in which gut-derived inflammation may increase Piezo1 activity through a PKA-related process, though this chain has only been shown in rats and cell cultures.
The study suggests that the increased sensitivity of muscle nerves may be one way that inflammation contributes to unusual circulation patterns during exercise in diabetes. Because the toxin exaggerated responses that were already present in diabetic animals, the findings hint that inflammation and diabetes may work together rather than separately. This could matter for understanding why some people with diabetes have larger blood pressure swings during physical activity.
The study also points to Piezo1 as a possible target for future research. Piezo1 is a protein that responds to physical force, and identifying a specific protein that amplifies signals could help scientists design more precise tests or treatments in the future. However, no treatment aimed at Piezo1 has been tested in people in this study.
Earlier research has shown that people with type 2 diabetes often have exaggerated blood pressure responses during exercise, and that muscle nerve signals called the muscle reflex play a role in this. This new study adds a possible molecular explanation by pointing to Piezo1 and gut-derived inflammation. Gut bacteria and inflammation have been increasingly linked to metabolic conditions such as diabetes and heart disease, so this work fits into a broader trend in research.
The findings build on past animal work showing that high-fat diets and blood sugar problems can change how nerves respond in muscle. Still, studies like this are usually a first step, and the specific pathway described here will need confirmation in other labs and in human studies.
The most important limitation is that the study was done in rats and in cell cultures grown in a dish. Rats are useful models, but their bodies and responses are not identical to human bodies, so the findings cannot be assumed to apply directly to people. The sample size was not specified in the information provided, which makes it harder to judge how strong the statistical evidence is.
The rats were also studied under anesthesia in some experiments, which can affect blood pressure and nerve activity. In addition, the diabetes in these rats was created using diet and a chemical, which may not perfectly match the way type 2 diabetes develops in people over many years. Finally, the study tested a limited set of pathways, so other factors that influence blood pressure during exercise were not measured.
The Bottom Line
At this stage, there are no specific recommendations for people based on this study. The research is preliminary and based on animal and cell experiments, so confidence that these results apply to humans is low. The findings are most useful as a guide for future research into gut health, inflammation, and blood pressure responses in diabetes. Anyone with diabetes who has concerns about blood pressure during exercise should follow standard medical advice and discuss their plan with a healthcare provider.
People with type 2 diabetes, researchers studying blood pressure and metabolism, and clinicians who care for patients with diabetes and blood pressure problems may find this work interesting. Those who already have a condition affecting blood pressure during exercise should talk with their doctor rather than making changes based on this study alone. Healthy adults without diabetes do not need to change their habits because of these findings.
Findings from early animal studies usually take years to be tested in people. Researchers would first need to confirm these results in other labs, then test whether the same pathway exists in humans, and only later consider whether any treatment or lifestyle guidance could be developed. Any real-world benefit is likely to be years away, and no immediate changes in daily life can be expected from this study alone.
Frequently Asked Questions
Does gut inflammation affect blood pressure during exercise in people with diabetes?
Current evidence is limited. A 2026 rat study found that a gut-derived inflammatory toxin strengthened blood pressure responses to muscle activity in diabetic animals. Researchers have not yet confirmed this pathway in humans, so people should not assume the same effect applies to them.
What is Piezo1 and why does it matter for blood pressure?
Piezo1 is a protein on cell surfaces that responds to physical pressure and stretching. In a 2026 rat study, the protein appeared to amplify nerve signals from muscles, which may contribute to larger blood pressure rises during activity. Its role in human blood pressure has not been confirmed.
Can I lower my blood pressure during workouts based on this new research?
This study does not provide a proven way to lower blood pressure during workouts. It was conducted in rats and cell cultures, so its findings are preliminary. People with diabetes or blood pressure concerns should follow their doctor’s exercise guidance and discuss any concerns with their healthcare provider.
Has this study been tested in humans with type 2 diabetes?
No, this research was conducted in laboratory rats and cells grown in a dish. Human studies are needed to determine whether the same nerve and protein pathway operates in people with type 2 diabetes. Until then, the findings should be viewed as early clues rather than established medical facts.
Want to Apply This Research?
- Users with diabetes who exercise may track their resting blood pressure and heart rate before and after a set workout, such as a 20-minute brisk walk, and log the readings in the app. Recording the same measurements at the same time of day each week helps show trends. Users should share these logs with their healthcare provider rather than using them to make medical decisions alone.
- Users can build a consistent routine of moderate, doctor-approved exercise and note how they feel afterward, including any dizziness or unusual shortness of breath. The app can prompt users to rest, hydrate, and check in with their provider if readings are unusually high. Users may also log meals and digestive symptoms, since the study points to gut-related inflammation as a possible area of interest, although this link is not yet established in people.
- A long-term approach is to keep a monthly summary of blood pressure, blood sugar readings, exercise sessions, and any digestive symptoms. Reviewing these trends with a healthcare provider every few months can help identify patterns that deserve attention. The app should update users if new human research connects gut health or Piezo1 to blood pressure, so they can make informed conversations with their care team.
This article summarizes a preliminary study conducted in laboratory rats and cell cultures, not in people. The findings may not apply to humans and should not be used to start, stop, or change any medication, exercise plan, or diet. Anyone with diabetes, high blood pressure, or digestive concerns should consult a qualified healthcare provider before making health decisions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.